Cystic Fibrosis Foundation distributed the following clinical trial updates during the month of December. Click the trial title to get more details.
The following alert was issued on December 1, 2017:
Sweat chloride observational study
Status: Enrolling
Description: This study is taking place at multiple care centers across the U.S. It will look at sweat chloride concentration in people who are currently taking CFTR modulators.
Age: 4 Months and Older
Mutation: No Mutation Requirement
Fev1% Predicted: No FEV1 Limit
Number of Visits: 1
Length of Participation: 1 days
ClinicaTrial,gov link:https://clinicaltrials.gov/ct2/show/NCT03350828